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ABSTRACT  
3D printing is a new innovative manufacturing method for fabrication of customized medical devices. The customized medical devices & long-
lasting implantable devices.has increasing demand for addressing some critical cases in surgeries.  
The main aim of this work was to explore the potential of 3D printing in Fabrication of medical devices and prosthetics. The characters of the 
polymers, the features of softwares were studied. 
The study showed that drug loading into filament through hot melt extrusion and followed by 3D printing has many defects such as denaturing 
of drugs at higher printing temperatures.  
The invention discloses the dip coating process  after fabrication of a 3D printed polymer structure. The drug release depends up on the surface 
area of the device, coated polymer, concentration of drug and thickness of the coat.  
The method for preparing the personalized drug eluting coronary stent / Bone wedges / Braces comprises the step that according to image data 
of coronary angiogram or volume rendered data from CT scans. The designing was done by adopting a QCA technique for measuring the 
diameter of a diseased coronary artery and reconstructing in a three-dimensional manner. According to indexes such as lesion vascular 
diameter, lesion length and lesion vascular pattern, a personalized coronary stent can be made for each patient in a customized manner and a 
stent most suitable for the lesion state of a patient can be prepared. 
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Medical device means any instrument, apparatus, implant, 
machine, appliance, implant, in vitro reagent or calibrator, 
software, material or other similar or related articles, 
intended by the manufacturer to be used, alone or in 
combination, for human beings for one or more of the 
specific purposes like diagnosis, prevention, monitoring, 
treatment or alleviation of disease; diagnosis, monitoring, 
treatment, alleviation of or compensation for an injury; 
investigation, replacement, modification or support of the 
anatomy or of a physiological process; supporting or 
sustaining life; control of conception; disinfection of medical 
devices and providing information for medical purposes by 
means of in vitro examination of specimens derived from the 
human body and does not achieve its primary intended 
action in or on the human body by pharmacological, 
immunological or metabolic means, but may be assisted in its 
function by such means 
There are many new innovative manufacturing like CNC 
laser cutting [2],Injection Molding [3], and 3D Printing [3][4][5][6].  
3D Printing have more Precision and have more advantages 
compared to injection molding[7]. 3D printing is an additive 
manufacturing process which creates a physical object from 
a digital design, by laying down thin layers of material in the 
form of liquid or powdered polymers, metal or cement which 
is fused together [8]. 
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However, 3D printing speeds are still too slow for mass 
production. For now, the technology is mainly reducing the 
lead time in the development of prototypes of parts and 
devices, and the tooling needed to make them. This is a huge 
benefit to smaller scale manufacturers because it reduces 
costs and time to market. Because 3D printing can create 
intricate and complex shapes using less material than 
subtractive manufacturing processes like milling[9]. 
Literature Survey: 
While currently used primarily to manufacture prototypes 
and mockups, a number of promising applications exist in 
the production of replacement parts, dental crowns, and 
artificial limbs,bone wedges, implants as well as in bridge 
manufacturing. Antonio J. Guerra  , Paula Cano Authors has 
worked to produce PCL/PLA composite stents using a novel 
3D tubular printer based on Fused Deposition Modeling 
(FDM)[10] . 
Antonio J. Guerra , Paula Cano proved that the 3D-printing 
process was highly suitable for producing composite 
stents[11]. Yang Lei, Xin Chen had manufactured a high 
efficient personalized stent by additive manufacturing (3D 
printing) has gained deal of attention and research in 
interventional and personalized medicine[12]. 
FDA-approved 3D printed implants by Osseus Fusion 
systems that are patient-specific where the implant is 
designed with that specific patient’s anatomy in 
mind.Degenerative Disc Disease, for example, affects more 
than 30 million people a year, and tends to occur as bone 
density decreases in a person’s later years, drying out and 
shrinking their discs, which in turn tightens the space around 
the nerves and spinal cord. In an attempt to prevent pains 
occurring, surgeons will look to remove the worn disc and 
replace it with a titanium interbody[13] 
It is necessary to have proper understanding of medical 
device safety, risk involved, the degree of invasiveness, 
duration of contact, the body system affected, and local 
versus systemic effects. Pharmacist should be actively 
involved in the regulation of effectiveness and performance 
of medical device. Clinical effectiveness is a good indicator of 
device performance, which is closely linked to safety. 
Pharmacists should be involved in the documentary of 
standards containing technical specifications or other 
precise criteria to be used consistently as rules, guidelines or 
definitions of characteristics, to ensure that materials, 
products, process and services are fit for their purpose. One 
has to ensure that the prescriptive, design, performance, and 
management specifications meet the standards [1]. 
XIAOHUA LIU1 and PETER X. MA has described two major 
disadvantages of Metals and ceramics for tissue engineering 
applications: they are lack of degradability in a biological 
environment, and their process ability is very limited. In 
contrast, polymers have great design flexibility because the 
composition and structure can be tailored to the specific 
needs [14]. 
Bret D. Ulery et al.[15], A. Ashwin Kumar et al.[16], 
AnezkaLengalova et al.[17]Shenguo Wang et al.[18]Mark 
Chasin& Robert Langer[19] , had described the use of 
biodegradable polymers in Tissue engineering, Implantable 
medical devices, Prosthetics & other medical 
applications.MihaiRusu et al.[20], Bret D. Ulery et al.[21],  had 
described the uses of Polycaprolactone in medical 
applications and A. Anand et al.[22], M. Kammerer et al.[23] had 
used Polycaprolactone for fabrication of implantable medical 
devices. 
Jenny Hollander et al [24] fabricate drug-containing T-shaped 
prototypes of intrauterine system (IUS) with the drug 
incorporated within the entire backbone of the medical 
device using 3-dimensional (3D) printing technique, based 
on fused deposition modeling 
Software Methods 
DICOM format[25] 
A DICOM file is an image saved in the Digital Imaging and 
Communications in Medicine (DICOM) format. The DICOM 
format was developed by the NEMA (National Electrical 
Manufacturers Association). It was designed for the 
exchanging and viewing of medical images, such as CT scans, 
MRIs, and ultrasound images. It contains an image from a 
medical scan, such as an ultrasound or MRI. DICOM files may 
also include identification data for patients so that the image 
is linked to a specific individual. 
There are various softwares for viewing dicom files like 
MICRO DICOM[26]and MEDDREAM DICOM[27] viewer. The 
diameters of vessels and measurements can be taken by 
measurement and various tools in the softwares. 
Download free software from 
http://www.microdicom.com/downloads.html . 
We can also download free sample dicom file from various 
DICOM databases like osirix. 
 
 
Fig.1 Microdicomdicom viewer software 
Akki et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(6-s):148-154 
ISSN: 2250-1177                                                                                  [150]                                                                                 CODEN (USA): JDDTAO 
Slicer Software[28] 
The slicer software is used to obtain the data from a CT-scan 
for visualizing and analysis of tissues and to obtain data for 
designing customized medical devices like Bone wedges , 
implants , prosthetics etc.slicer is a completely free open-
source software for visualization and image analysis. this 
software has wide set of features like converting DICOM files 
to STL files and in which ever format we need. The features 
and capabilities of Slicer software was explained in slicer 
wiki. The slicer software can be installed directly from slicer 
software official website. 
 
 
Fig2.3D Slicer software. 
 
Computer Aided Design & Drafting 
The design was patient-specific where the implant is 
designed with that specific patient’s anatomy in mind.[29].the 
design was done on CADD softwares like Autodesk 
AUTOCAD or SOLIDWORKS software 
 
. 
Fig3. Designing of Device in CADD software. 
 
STL file format.[29] 
STL (an abbreviation of "stereolithography") is a file format 
native to the stereolithography CAD software created by 3D 
Systems. STL has several backronyms such as "Standard 
Triangle Language" and "Standard Tessellation Language". 
This file format is supported by many other software 
packages; it is widely used for rapid prototyping, 3D printing 
and computer-aided manufacturing.STL files describe only 
the surface geometry of a three-dimensional object without 
any representation of color, texture or other common CAD 
model attributes. 
3D Printing software [30] 
The slicer, also called slicing software, is computer software 
used in the majority of 3D printing processes for the 
conversion of a 3D object model to specific instructions for 
the printer. In particular, the conversion from a model in STL 
format to printer commands in g-code format in fused 
filament fabrication and other similar processes. 
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Fig4. FLASHFORGE FLASHPRINT slicer software. 
 
Fused Deposition Modelling (3D Printing)[31] 
The most common 3D printing technology is called the Fused 
Deposition Modelling (FDM) which utilises thermoplastic 
filaments as a starting material, then extrudes the material in 
sequential layers above its melting temperature to create a 
3D object. . Fused deposition modeling (FDM) is a promising 
3D printing technique for the fabrication of personalized 
drug dosage forms and patient-specific implants[32].
 
 
Fig 5.3D Printing of The device prototype. 
MATERIALS AND METHODS 
Materials 
Polylactic acid filaments 1.75mm was used for fabrication of 
the core structure of the device and Polycaprolactone was 
used in coating process. Aspirin was selected as a model 
drug & Ethyl acetate was selected as solvent for dip coating . 
The Polymer used in coating was polycaprolactone and the 
polymer used in fabricating the basic structure was 
polylactic acid. The solvent ethyl acetate was selected as the 
core structure would not be soluble and the polymer used in 
coating process must be soluble. 
Methods 
Zhou Yujie et al., in his patent [32] had explained The method 
for preparing the personalized drug eluting coronary stent 
comprises the step that according to image data of coronary 
angiogram, adopting a QCA technique for measuring the 
diameter of a diseased coronary artery and reconstructing in 
a three-dimensional manner.  
According to indexes such as lesion vascular diameter, lesion 
length and lesion vascular pattern, a personalized coronary 
stent can be made for each patient in a customized manner 
and a stent most suitable for the lesion state of a patient can 
be prepared. The most suitable personalized bionic drug 
eluting coronary stent can be customized for the patient 
according to diseased coronary arteries of different states, 
requirements of different lesions can be met, customization 
of coronary stents can be achieved, and complications such 
as vascular injury, thrombus and coronary arterial 
dissection caused by mismatching of the diameter of the 
stent and that of the blood vessel can be reduced. 
Jenny Hollander et al [24] fabricate drug-containing T-shaped 
prototypes of intrauterine system (IUS) with the drug 
incorporated within the entire backbone of the medical 
device using 3-dimensional (3D) printing technique, based 
on fused deposition modeling. According to Antonio J. 
Guerra et al.,[10]  Polycaprolactone has less accuracy and  less 
printability during complex structure fabrication. The 
temperature during 3D printing can damage the 
Thermolabile drugs during 3D printing process or Hot melt 
extrusion of filaments. 
The Present study discloses the dip coating process[33] after 
fabrication of a 3D printed polymer structure. The drug 
release depends up on various factors likecrystallinity of 
drug surface area of the device, coated polymer, 
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concentration of drug and thickness of the coat.Three 
different concentrations of Aspirin in the polymer, namely 
5%, 10%, and 20%, were selected for the coating process. 
Polylactic acid filaments 1.75mm was used for fabrication of 
the core structure of the device and Polycaprolactone& 
aspirin was mixed in different concentrations namely 5%, 
10%, and 20%. Ethyl acetate was selected as solvent for dip 
coating of printed structures. The solvent ethyl acetate was 
selected as the core structure would not be soluble and the 
polymer used in coating process must be soluble. 
Rheology Measurement[24]. 
Rheology measurements were carried out to determine the 
viscosity of the polymer solutions for dip coating. The 
experiments were conducted with a rotational rheometer 
equipped with 2 parallel plates of 15 mm in diameter. 0.6 g 
of the sample was placed on the lower plate and the upper 
plate was lowered until there was 1 mm gap between the 
plates, and the sample was sheared between the plates. The 
viscosity was calculated as the ratio between the applied 
shear stress and the shear rate. 
In Vitro Drug Release[34] 
The drug release experiments were conducted with coated 
devices, containing different amounts of drug loading. Each 
sample was exactly weighed and placed in a compression 
spring made of stainless steel that was attached to the metal 
rod connected to the cap of a 250-mL bottle. This assembly 
was needed to prevent the samples from lying on the bottom 
of the release vessel as the density of PCL is higher than the 
density of the release medium and is equal to 1.1 g/cm3.  
Each sample was immersed into 200 mL of 0.9% sodium 
chloride. The bottles were placed on a shaking bath at 37.0 ± 
0.2C with shaking speed of 100 rpm for 30 days. The release 
media was exchanged when needed to maintain sink 
conditions. Samples were taken at defined time points, and 
the concentration of indomethacin in the release medium 
was measured spectrophotometrically at 265 nm. 
Matrix Degradation During In Vitro Release Tests  
To determine the mass loss of the polymer, the samples after 
the dissolution tests were dried at room temperature 
overnight and then weighed. The mass loss calculations 
were derived from the actual drug polymer ratio, obtained 
from drug content analysis. The released indomethacin 
percentage and polymer mass loss were calculated as 
follows: 
Drug release percent (%)= [Weight of drug released/Total 
actual weight of drug]x100% 
Mass loss of the polymer (%) =[(The initial weight of sample 
-  the final weight of sample - the weight drug released)/ 
Total actual weight of the polymer] x 100% 
X-Ray Diffraction 
The degree of crystallinity of raw materials, their binary 
mixture (referred to the mixture of drug and polymer 
components prepared in the mortar), and HME filaments 
were studied with the help of an X-ray diffractometerXRD 
scans were performed in Ɵ/2Ɵ Bragge Brentano geometry 
using CuKa radiation (ƛ= 1.54 Å) with a voltage of 40 kV and 
a current of 50 mA, using a PIXcel 1D detector. [24]the 
samples were prepared by coating the polymer coating 
solution on a prototype that can fit in a sample holder. 
Fourier Transform Infrared Spectroscopy (FT-IR) [35] 
Structural characterization of the Polymer & the drug and 
interactions between them were carried out by Fourier 
Transform Infrared Spectroscopy (FT-IR) using a Bruker 
spectrometer (Dept of Analysis,Hindu college of 
Pharmacy,AP). The spectra were recorded at ambient 
temperature between 400 and 4000 cm−1. 
Differential Scanning Calorimetry 
The differential scanning calorimetry is a tool used to 
measure the temperature and energy variation involved in 
the phase transitions, which reflects the degree of 
crystallinity and stability of the solid state of pharmaceutical 
compounds. The peak size and shape of the DSC curves are 
useful in determining the crystallinity of the drug and the 
carrier. In order toanalyze the association of aspirin with 
PCL,  
RESULTS 
In Vitro Drug Release 
The in vitro drug release data for the PCL samples were 
fitted by zero-order, first-order, Higuchi, and Korsmeyere 
Peppas models The best fit was obtained with the zero order 
model (R2> 0.99 values for all samples), indicating that the 
diffusion is the predominant release mechanism of the drug 
from PCL polymer, regardless of the geometry of the 
samples and the amount of drug loading. 
 
 

























F1 drug release in mg
F2 drug release in mg
F3 drug release in mg
F4 drug release in mg
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Table 1: Drug release kinetics of formulations F1,F2,F3. 
Formulation Zero order R2 
Mt/M∞ = Q0+k0t  
First order R2 
LogC= logC0- kt/2.303 
 
Higuchi R2 
Mt/M∞ = kH .t1/2 
Kormeyers-Peppas 
Mt/M∞= ktn 
R2 release exponent n 
F1 NA NA NA NA NA 
F2 0.997 0.9767 0.8567 0.9058 1.056 
F3 0.995 0.9623 0.8539 0.9162 0.997 





The peak at 1605 cm −1 is due to the benzene ring, whereas 
the absorption peak at 1680 cm −1 is due to the presence of 
carbonyl group in aspirin. These absorption peaks 
corresponded to the characteristic peaks of aspirin as 
described by Li et al (1991)[36]. The characteristic 
absorption bands at 2942 and 2865 cm-1 are related to C-H 
stretching vibration of hydrocarbon of PCL. The band at 
1721 cm-1 is ascribed to the stretching vibration of 
carbonyl groups (C=O) of PCL[37]. 
Matrix Degradation During In Vitro Release Test: 
The degradation of PCL is a 2-phase process with an initial 
molecular weight loss due to chain scission without a 
significant weight loss. When the loss of molecular weight 
is up to 5000, the mass loss begins due to the diffusion of 
small polymeric fragments out of the matrix[38].the mass 
loss of polymer was nearly 52% , 60% , 65%, 69% for F1-
F4 formulations. The polymer degradation was very slow 
that it took over a month to degrade a thin coat of polymer. 
Differential Scanning Calorimetry; 
DSC analysis was performed on aspirin, PCL, and the 
aspirin-PCL mixture. The results of the DSC test confirmed 
there was no association of aspirin and PCL in the mixture 
as both peaks representing aspirin and PCL does not 
changed positions ,while aspirin showed a sharp 
endothermic peak at 142.60C. 
 
CONCLUSION:  
The new innovative methods like injection moulding, CNC 
laser cutting and 3D printing has wide applications and has 
been employed in the manufacturing of medical Devices 
And  implantable devices. 3D Printing is the process that 
can fabricate even tough and high complex designs.The 
methodology and software methods has been studied. the 
polymers used in fabrication has several advantages and 
their biocompatibility offers quality goal. Dip coating is 
used for coating a material used in sustain release 
mechanism The percentage of the dissolved drug was 
higher in the products with lower drug content.  In vitro 
study reveals that diffusion was the predominant 
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mechanism of the drug release from the coat insignificant 
influence by PCL biodegradation. Polycaprolactone had 
eroded and degraded very slowly that the loss is nearly 50-
60% in a month.  Further studies will be performed to 
develop a design space for all other factors live coat 
surface area, polymers mixture ratios, polymer grades etc. 
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